Skip to main content

Showing 171 - 180 of 2656 results

JAMDA

December 15, 2014

A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD)

Neuropsychiatric symptoms in Alzheimer disease (AD) cause significant distress and present a complex clinical challenge for treatment. Pharmacological treatment options are limited to antipsychotics, which carry extensive safety issues. There is emerging evidence to support the potential benefits of memant...
Policy Snapshot

March 31, 2026

Make Your Voice Heard: Fix Practice Expense Cuts in Skilled Nursing Facilities

Contact the Centers for Medicare & Medicaid Services regarding recent reductions to Practice Expense (PE) RVUs for services in Skilled Nursing Facilities (POS 31). These cuts create an artificial payment difference that does not reflect clinical reality. There is no meaningful difference in the cost of...